Risteys ·

OMOP concept ID	Test name	Measurement unit (harmonized unit)	N people	N records	Missing measurement value	Harmonized value distribution	Test outcome NA N A AA L LL H HH
3037377	u-dxpro-o	— (—)	89	106	100.00%	Distribution not available

LabWAS

N Cases

N Controls

-log₁₀(p)

cases

controls

cases

controls

unit

-log₁₀(p)

N cases

N controls

Sleep apnoea, including avohilmo

2.67

3.91

1.0

1.3

—

Sleep disorders (combined)

2.41

3.25

1.2

—

Sleep apnoea

2.51

3.09

1.1

1.3

—

Hyperkinetic disorders, excluding more controls

5.59

2.91

1.1

—

Injuries to the wrist and hand

2.27

2.85

1.5

1.1

—

Persons encountering health services for other counselling and medical advice, not elsewhere classified

2.23

2.82

1.2

—

Disturbance of activity and attention

4.58

2.55

1.1

1.5

—

Persons encountering health services in other circumstances, wide

2.11

2.49

1.2

—

Hyperkinetic disorders

4.29

2.42

1.1

1.4

—

Substance use, excluding alcohol

3.64

2.36

1.8

1.1

—

Behavioural and emotional disorders with onset usually occurring in childhood and adolescence

3.34

2.35

1.1

1.5

—

Special screening examination for infectious and parasitic diseases

2.89

2.31

1.3

1.2

—

Assault

3.89

2.25

2.0

1.2

—

Anxiety disorders

2.05

2.18

1.7

1.0

—

Superficial injury of lower leg

3.69

2.15

1.0

1.3

—

Striking against or struck by other objects

2.78

2.13

1.3

1.4

—

Anxiety disorders, excluding more controls

2.09

2.05

1.7

1.0

—

Episodal and paroxysmal disorders

1.98

1.97

1.2

—

Cough

3.31

1.94

1.0

1.3

—

Localized swelling, mass and lump of skin and subcutaneous tissue

3.75

1.93

1.3

1.1

—

General examination and investigation of persons without complaint and reported diagnosis

2.24

1.89

1.5

1.2

—

Chronic diseases of tonsils and adenoids

2.07

1.88

1.1

1.2

—

Persons with potential health hazards related to communicable diseases

2.37

1.81

1.1

1.3

—

Neurotic, stress-related and somatoform disorders

1.93

1.80

1.7

1.0

—

Herpesviral [herpes simplex] infections

3.33

1.74

1.0

1.4

—

Congenital malformations, deformations and chromosomal abnormalities

2.00

1.67

1.1

1.2

—

Appendicitis, broad definition

1.99

1.65

1.3

1.2

—

Other diseases of upper respiratory tract

1.90

1.65

1.0

1.2

—

Diseases of appendix

1.99

1.64

1.3

1.2

—

Antihypertensive medication - note that there are other indications

2.02

1.62

1.3

1.2

—

Other sexually transmitted chlamydial diseases

3.57

1.61

1.0

1.1

—

Myalgia

3.57

1.61

1.0

1.5

—

Other anxiety disorders

2.17

1.60

1.8

1.1

—

Peritonsillar abscess

3.00

1.58

1.0

1.5

—

Acute tubulo-interstitial nephritis

2.46

1.54

1.0

1.3

—

Acute appendicitis

1.98

1.54

1.3

1.2

—

Other antidepressants

1.84

1.50

1.4

1.1

—

Congenital malformations, deformations and chromosomal abnormalities

1.96

1.50

1.1

1.2

—

Anxiety (asthma-related co-morbidities)

1.93

1.49

1.7

1.1

—

Nonsuppurative otitis media

2.88

1.49

1.0

1.3

—

Neurological diseases

1.90

1.47

1.2

—

Nonorganic sleeping disorders, excluding more controls

3.13

1.44

1.4

1.1

—

Any gastric operation

1.84

1.43

1.4

1.1

—

GASTRO-related operations

1.84

1.43

1.4

1.1

—

All anxiety disorders

1.88

1.40

1.7

1.0

—

Type of accident

2.61

1.36

1.2

—

Migraine, single triptan purchase ok & required. ICD-code if available is included

1.84

1.36

1.5

1.1

—

Triptan medication for migraine, single purchase ok

1.84

1.36

1.5

1.1

—

Excessive earwax

2.36

1.34

1.0

1.2

—

Hypothyroidism, strict autoimmune, 3 medication purchases required

2.03

1.32

1.0

1.3

—

Insomnia

1.77

1.31

1.5

1.1

—

Hypothyroidism, strict autoimmune

2.02

1.31

1.0

1.3

—

Ovarian cyst

2.66

1.30

1.0

1.5

—

Hypothyroidism, other/unspecified

1.94

1.29

1.0

1.3

—

Acute appendicitis, no complications

1.93

1.26

1.3

1.2

—

Supplementary factors related to causes of morbidity and mortality classified elsewhere

2.40

1.24

1.2

—

Sleep disorders

1.73

1.23

1.5

1.1

—

Nonorganic sleeping disorders

2.63

1.21

1.4

—

Hypothyreosis and Thyroxine purchase for inclusion criteria

1.89

1.21

1.0

1.3

—

Follow-up examination after treatment for conditions other than malignant neoplasms

2.21

1.21

1.3

—

Artrosis, including avohilmo

0.43

1.19

1.0

1.2

—

Other retinal disorders

0.00

1.17

0.0

1.3

—

Contact with and exposure to communicable diseases

2.04

1.14

1.1

1.3

—

Acute upper respiratory infections of multiple and unspecified sites

1.79

1.14

1.0

1.2

—

Abnormalities of breathing

1.70

1.13

1.4

1.2

—

Cholecystectomy

2.03

1.13

1.3

1.2

—

Codeine

1.74

1.12

1.3

1.1

—

Dislocation, sprain and strain of joints and ligaments at wrist and hand level

2.33

1.12

1.9

1.1

—

Other reaction to severe stress, and adjustment disorders

2.00

1.12

1.0

1.1

—

Opioids

1.70

1.10

1.5

1.1

—

Other and unspecified effects of external causes

2.26

1.10

1.1

1.4

—

Open wound of wrist and hand

1.95

1.09

1.4

1.1

—

Depression or dysthymia

1.96

1.08

1.4

1.0

—

All pneumoniae

0.48

1.08

1.3

1.2

—

Pneumonias (Asthma/COPD co-morbidities)

0.49

1.08

1.3

1.2

—

Menorrhagia

2.52

1.08

1.0

1.5

—

Codeine or tramadol medication

1.62

1.07

1.2

—

Hypothyroidism, levothyroxine purchases

2.20

1.06

1.0

—

Hypothyroidism and >3 levothyroxin purchases

2.20

1.06

1.0

—

Hypothyroidism (congenital or acquired)

2.20

1.06

1.0

—

Selective serotonin reuptake inhibitors

1.67

1.06

1.2

1.1

—

Osteopathies and chondropathies

2.10

1.04

1.0

1.4

—

Persons with potential health hazards related to family and personal history and certain conditions influencing health status

0.46

1.04

1.0

1.2

—

Injuries to the neck

2.27

1.03

1.4

—

Chronic rhinitis, nasopharyngitis and pharyngitis

2.27

1.03

1.0

1.5

—

Transport accidents

1.89

1.00

1.3

1.1

—

Chronic sinusitis

2.00

0.99

1.0

1.3

—

Mental and behavioural disorders due to psychoactive substance use

1.82

0.99

1.8

1.1

—

Abdominal and pelvic pain

1.61

0.99

1.6

1.1

—

Erosion of teeth , including avohilmo

0.00

0.97

0.0

1.3

—

Injuries to the thorax

1.94

0.97

1.4

1.2

—

Spontaneous abortion

2.38

0.96

1.5

1.3

—

Fracture at wrist and hand level

1.94

0.96

1.1

1.2

—

Medical abortion

2.00

0.96

1.3

—

All chronic kidney diseases

0.00

0.95

0.0

1.3

—

Tonsillectomy and adenotomy

1.68

0.95

1.0

1.3

—

Erysipelas

1.79

0.92

1.4

1.2

—

Behavioural syndromes associated with physiological disturbances and physical factors

1.60

0.91

1.5

1.1

—

Influenza and pneumonia

0.54

0.91

1.4

1.2

—

Mood [affective] disorders

1.57

0.90

1.6

1.1

—

Procreative management

1.96

0.90

1.3

1.2

—

Mood disorders

1.57

0.90

1.6

1.1

—

Exposure to unspecified factor

1.58

0.88

1.1

1.2

—

Mouth breathing

2.00

0.86

1.3

1.2

—

Pneumonia (excl. viral and due to other infectious organisms not elsewhere classified)

0.53

0.85

1.3

1.2

—

Sensorineural hearing loss

1.94

0.83

1.3

1.1

—

Ischaemic heart disease, wide definition

1.77

0.83

1.0

1.1

—

Genitourinary diseases

0.49

0.82

1.6

1.2

—

Hyperplasia of prostate

0.00

0.81

0.0

1.0

—

Keratitis

1.88

0.81

1.0

1.3

—

Autoimmune diseases excluding thyroid diseases, strict definition

0.56

0.81

1.0

1.2

—

Psychiatric diseases

1.57

0.81

1.7

1.0

—

Autoimmune diseases excluding thyroid diseases

0.55

0.81

1.0

1.2

—

Bacterial infection, other or unspecified

0.00

0.79

0.0

1.1

—

Substance abuse, excluding more controls

1.74

0.79

1.9

1.0

—

Bacterial pneumonia (organism specified)

0.00

0.79

0.0

1.2

—

Bacterial pneumoniae

0.00

0.79

0.0

1.3

—

Disorders of sclera, cornea, iris and ciliary body

1.67

0.78

1.0

1.3

—

Concussion

1.67

0.78

1.3

1.2

—

Diarrhoea and gastroenteritis of presumed infectious origin

1.53

0.78

1.1

1.2

—

Endometriosis

2.26

0.77

1.0

1.5

—

Substance abuse

1.71

0.76

1.9

1.1

—

Disorders of eyelid, lacrimal system and orbit

1.67

0.76

1.1

1.2

—

Medical treatment for female infertility

2.16

0.76

1.2

1.3

—

Maternal care for known or suspected abnormality of pelvic organs

2.13

0.75

1.2

1.1

—

Coronary atherosclerosis

1.84

0.74

1.0

1.1

—

Persons with potential health hazards related to socioeconomic and psychosocial circumstances

2.06

0.74

1.4

1.3

—

Pregnancy with abortive outcome

1.83

0.73

1.4

1.3

—

Triptan medication for migraine, min. 3 purchases

1.70

0.73

1.3

1.2

—

Anaemias

1.92

0.69

1.0

—

Intracranial trauma

1.67

0.69

1.4

1.2

—

Symptoms and signs involving the skin and subcutaneous tissue

1.54

0.69

1.2

—

Recurrent or chronic depression

1.64

0.67

1.6

1.0

—

Shoulder lesions

1.58

0.66

1.1

1.2

—

Disorders of the thyroid gland

1.54

0.66

1.0

1.3

—

Atrial fibrillation and flutter

1.80

0.65

1.6

1.2

—

Codes for special purposes

1.59

0.65

1.0

1.3

—

Provisional assignment of new diseases of uncertain etiology

1.59

0.65

1.0

1.3

—

Other pulmonary diagnosis

1.58

0.64

1.1

1.2

—

Excluding asthma or asthma-COPD overlap

1.58

0.64

1.1

1.2

—

Malignant neoplasm, wide definition for exclusion

0.57

0.64

1.0

1.2

—

Missing teeth due to accident, extraction or parodontitis

1.74

0.64

1.0

1.2

—

Carpal tunnel syndrome

1.58

0.64

1.1

1.3

—

Disorders of ocular muscles, binocular movement, accommodation and refraction

1.58

0.64

1.3

—

Metabolic disorders

0.58

0.64

1.0

1.2

—

Obesity, other/unspecified

1.72

0.64

1.0

1.3

—

Hernia

0.58

0.64

2.0

1.1

—

Medical observation and evaluation for suspected diseases and conditions

1.61

0.63

1.7

1.2

—

Injuries to the abdomen, lower back, lumbar spine and pelvis

1.71

0.63

2.4

1.2

—

Rotator cuff syndrome

1.64

0.62

1.0

1.2

—

Mood disorders, excluding more controls

1.49

0.62

1.7

1.0

—

Malignant neoplasm of breast, including Hilmo

0.00

0.62

0.0

1.3

—

Malignant neoplasm of breast, HER2-negative, including Hilmo

0.00

0.62

0.0

1.3

—

Acute bronchitis

1.69

0.62

1.0

1.4

—

Acute upper respiratory infections

1.49

0.62

1.0

1.2

—

Spinal stenosis

0.00

0.61

0.0

1.1

—

Acetic acid derivatives and related substances

0.00

0.61

0.0

1.0

—

Tramadol

1.62

0.61

1.7

1.1

—

Depression

1.45

0.61

1.3

1.1

—

Infections with a predominantly sexual mode of transmission

1.59

0.61

1.0

1.3

—

Non-invasive ventilation

0.00

0.61

0.0

1.1

—

UC patients in KELA-register ( KELA 208 prior to 1994, or ICD K51)

0.00

0.60

0.0

1.2

—

Other heart diseases, wide

0.59

1.4

1.2

—

Intracranial injury

1.54

0.59

1.5

1.2

—

Bacterial pneumonia, not elsewhere classified

0.00

0.59

0.0

1.2

—

Schizophrenia

0.00

0.59

0.0

1.2

—

Injury of muscle and tendon at shoulder and upper arm level

0.00

0.59

0.0

1.1

—

Superficial injury of head

0.00

0.59

0.0

1.2

—

COPD differential diagnosis

1.54

0.59

1.1

1.2

—

ILD differential diagnosis

1.54

0.59

1.1

1.2

—

Necrosis of pulp, including avohilmo

1.56

0.58

1.1

1.2

—

Pain in limb

0.57

1.0

1.2

—

Any mental disorder

1.43

0.57

1.7

1.0

—

Gastro-oesophageal reflux disease

1.47

0.56

1.0

1.2

—

Persons encountering health services for specific procedures and health care

0.63

0.56

1.4

1.2

—

Ischemic heart diseases

1.58

0.56

1.2

—

Examination and observation for other reasons

1.53

0.56

1.1

1.2

—

Other diseases of urinary system

0.60

0.54

1.0

1.3

—

Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism

0.61

0.53

1.3

1.2

—

Bronchitis

1.41

0.53

1.0

1.3

—

Pneumonia, organism unspecified

0.59

0.53

1.3

1.2

—

Asthma

1.52

0.52

1.0

1.2

—

Asthma, excluding more controls

1.51

0.51

1.0

1.2

—

Viral and other specified intestinal infections

1.48

0.51

1.0

1.4

—

Use of hypnotics and sedatives

1.39

0.49

1.5

1.1

—

Diseases of pulp and periapical tissues, including avohilmo

0.65

0.47

1.6

1.2

—

L04AX Other immunosuppressants

1.46

0.46

1.0

1.3

—

Condition for Implicit Sepsis (Organ dysfunction codes)

0.59

0.46

1.4

1.2

—

Other acute lower respiratory infections

1.45

0.46

1.0

1.3

—

Dizziness and giddiness

1.42

0.45

1.3

—

Migraine

1.42

0.45

1.3

—

Polyp of the female genital tract

0.00

0.42

0.0

1.6

—

Symptoms and signs involving the circulatory and respiratory systems

1.34

0.42

1.3

1.2

—

Other headache syndromes

1.56

0.42

1.0

1.3

—

Other cataract

0.00

0.42

0.0

1.1

—

Malignant neoplasm of breast, HER2-negative

0.00

0.41

0.0

1.3

—

Malignant neoplasm of breast

0.00

0.41

0.0

1.3

—

Other viral diseases, not elsewhere classified

0.00

0.41

0.0

1.1

—

Asthma-related pneumonia or sepsis

0.00

0.41

0.0

1.1

—

Asthma, hospital admissions 3, pneumonia

0.00

0.41

0.0

1.1

—

Asthma-related pneumonia

0.00

0.41

0.0

1.1

—

Cervicobrachial syndrome

0.00

0.41

0.0

1.3

—

Enthesopathies of lower limb, excluding foot

0.00

0.41

0.0

1.3

—

Calculus of kidney and ureter

0.00

0.41

0.0

1.1

—

Alcohol abuse, main dg, excluding more controls

0.00

0.41

0.0

1.1

—

Intentional self-poisoning by and exposure to other and unspecified chemicals and noxious substances

0.00

0.41

0.0

1.1

—

Urolithiasis

0.00

0.41

0.0

1.1

—

Childhood asthma (age<16)

0.00

0.41

0.0

1.4

—

Childhood asthma (age<16), excluding more controls

0.00

0.41

0.0

1.4

—

Symptoms and signs involving the digestive system and abdomen

1.34

0.41

1.5

1.1

—

Presence of other functional implants

0.00

0.41

0.0

1.1

—

Ulcerative colitis (strict definition, require KELA, min 2 HDR)

0.00

0.40

0.0

1.1

—

Cellulitis

0.00

0.40

0.0

1.1

—

In situ neoplasms

0.00

0.40

0.0

1.5

—

Acute nasopharyngitis (common cold)

0.00

0.40

0.0

1.1

—

Injuries to the elbow and forearm

1.33

0.40

1.1

1.2

—

Atopic dermatitis, strict definition

1.44

0.39

1.0

1.3

—

Ulcerative colitis (strict definition, require KELA)

0.00

0.39

0.0

1.3

—

Pedal cyclist injured in transport accident

0.00

0.39

0.0

1.3

—

Abrasion of teeth

0.00

0.39

0.0

1.2

—

Renal tubulo-interstitial diseases

1.34

0.38

1.2

1.3

—

Atopic dermatitis, strict definition with reimbursement

1.38

0.38

1.0

1.3

—

Other bacterial diseases

1.33

0.37

1.3

1.2

—

Neurological diseases, wide definition

1.51

0.37

1.2

1.1

—

Fall on same level

1.29

0.37

1.2

—

Any reimbursement code in KELA

1.37

0.36

1.2

1.3

—

Appendectomy

1.39

0.36

1.6

1.1

—

Diarrhoea and gastroenteritis of presumed infectious origin

0.63

0.35

1.0

1.2

—

Conductive and sensorineural hearing loss

1.40

0.35

1.3

1.1

—

Erysipelas

1.40

0.35

1.7

1.2

—

Injury, poisoning and certain other consequences of external causes

1.37

0.35

1.2

1.0

—

Other joint disorders

1.30

0.34

1.3

1.2

—

Headache

1.38

0.34

1.1

1.2

—

Disorders of skin appendages

1.36

0.34

1.7

1.2

—

Diseases of vocal cords and larynx+other diseases of upper respiratory tract, no elsewhere classified

1.36

0.34

1.3

—

Statin medication

0.66

0.34

1.0

1.3

—

Chronic lower respiratory diseases

1.26

0.32

1.0

1.2

—

Asthma (mode)

1.37

0.32

1.0

1.2

—

Percutaneous Coronary Intervention

1.34

0.31

1.3

1.2

—

Coronary revascularization (ANGIO or CABG)

1.34

0.31

1.3

1.2

—

Diseases of the ear and mastoid process

1.25

0.31

1.3

1.2

—

Second line medication for Crohn's disease

1.35

0.31

1.0

1.3

—

General symptoms and signs

1.25

0.31

1.4

1.2

—

COPD/asthma/ILD related infections

0.74

0.30

1.3

1.2

—

COPD/asthma related infections

0.74

0.30

1.3

1.2

—

Injuries to the knee and lower leg

1.25

0.29

1.1

1.2

—

Other and unspecified tonsillitis

1.25

0.29

1.0

1.3

—

Diseases of the skin and subcutaneous tissue

0.76

0.29

1.3

1.2

—

Intestinal infectious diseases

1.26

0.29

1.1

1.2

—

Gingivitis and periodontal diseases

0.76

0.28

1.2

—

Finngen Rheumatological endpoints

0.75

0.28

1.0

1.2

—

Disorders of lipoprotein metabolism and other lipidaemias

0.69

0.27

1.0

1.2

—

Asthma, including avohilmo

1.23

0.26

1.1

1.2

—

Implicit Sepsis

0.68

0.26

1.4

1.2

—

Persons encountering health services in circumstances related to reproduction

1.24

0.26

1.0

1.1

—

Other disorders of ear

1.23

0.25

1.2

—

Atopic dermatitis

1.23

0.25

1.0

1.3

—

Accidents

0.70

0.25

1.5

1.1

—

Cardiac arrhythmias

0.74

0.24

1.5

1.2

—

Other maternal disorders predominantly related to pregnancy

1.31

0.23

1.2

1.3

—

Fracture of forearm

1.31

0.23

1.0

1.3

—

Gestational diabetes (for exclusion)

1.29

0.23

1.0

1.3

—

Disorders of gallbladder, biliary tract and pancreas

0.75

0.23

1.0

1.2

—

Other bacterial diseases

0.76

0.23

1.6

1.2

—

Complications of labour and delivery

1.26

0.23

1.2

1.3

—

Irregular menses

1.27

0.23

1.4

1.2

—

Disorders of conjunctiva

0.77

0.22

1.0

1.2

—

Postpartum care and examination

0.00

0.22

0.0

1.0

—

Other malignant neoplasms of skin (=non-melanoma skin cancer), including Hilmo

0.00

0.22

0.0

1.1

—

Diabetes, insuline treatment (Kela reimbursement), excluding more controls

0.78

0.22

1.0

1.2

—

Gonarthrosis, primary, with knee surgery

0.00

0.21

0.0

1.0

—

Malignant neoplasm of breast, HER-positive

0.00

0.21

0.0

1.2

—

Crowding of teeth, including avohilmo

0.00

0.21

0.0

1.1

—

Malignant neoplasm of breast, ER-positive, including Hilmo

0.00

0.21

0.0

1.2

—

Diabetes, insulin treatment (Kela reimbursement)

0.75

0.21

1.0

1.2

—

Diabetic retinopathy, strict definition

0.00

0.21

0.0

1.0

—

Type1 diabetes, definitions combined, early onset

0.00

0.21

0.0

1.1

—

Personal history of other diseases and conditions

0.00

0.21

0.0

1.2

—

Type 1 diabetes, strict definition

0.00

0.21

0.0

1.4

—

Type 1 diabetes, strict definition, subgroup 1

0.00

0.21

0.0

1.4

—

Eustachian salpingitis and obstruction

0.00

0.21

0.0

1.3

—

Multiple gestation

0.00

0.21

0.0

1.1

—

Embedded teeth, including avohilmo

0.00

0.21

0.0

1.1

—

Type 1 diabetes, strict (exclude DM2)

0.00

0.21

0.0

1.4

—

Type 1 diabetes, definitions combined

0.00

0.21

0.0

1.4

—

Alcohol abuse, main dg

0.00

0.21

0.0

1.1

—

Pain in thoracic spine

0.00

0.21

0.0

1.2

—

Certain disorders involving the immune mechanism

0.00

0.21

0.0

1.2

—

Psoriasis vulgaris

0.00

0.21

0.0

1.1

—

Coagulation defects, purpura and other haemorrhagic conditions

0.00

0.21

0.0

1.2

—

Thyrotoxicosis, other and/or unspecified

0.00

0.21

0.0

1.4

—

Glaucoma suspect

0.00

0.21

0.0

1.2

—

Dental pulpitis, including avohilmo

1.21

0.21

1.1

1.2

—

Diabetic retinopathy, excluding more controls

0.00

0.21

0.0

1.0

—

1.18

0.21

1.0

1.3

—

Hypertrophy of breast in women and men

0.00

0.21

0.0

1.3

—

Ganglion

0.00

0.21

0.0

1.6

—

Retinal detachments and breaks

0.00

0.21

0.0

1.2

—

Paroxysmal tachycardia

0.00

0.21

0.0

1.1

—

Diabetic retinopathy

0.00

0.21

0.0

1.0

—

0.80

0.21

1.0

1.2

—

Hyperlipidaemia, other/unspecified

0.00

0.21

0.0

1.0

—

Dermatitis and eczema

0.80

0.21

1.0

1.2

—

Reimbursement for rheumatic diseases

1.16

0.21

1.0

1.3

—

Dislocation, sprain and strain of joints and ligaments at ankle and foot level

1.16

0.21

1.4

1.3

—

Postpartum haemorrhage due to anatomy

0.00

0.21

0.0

1.6

—

Inflammatory disease of uterus

0.00

0.21

0.0

1.6

—

Ulcerative colitis (strict definition, all Crohn cases excluded)

0.00

0.21

0.0

1.2

—

Carbimazole or st.post thyroidectomy, condition for graves disease

0.00

0.21

0.0

1.3

—

Disorders of vitreous body

0.00

0.20

0.0

1.2

—

Malignant neoplasm of skin

0.00

0.20

0.0

1.2

—

Diabetes, varying definitions

0.78

0.20

1.0

1.2

—

Glaucoma

0.00

0.20

0.0

1.2

—

Presence of cardiac and vascular implants and grafts

0.00

0.20

0.0

1.0

—

Polycystic ovarian syndrome, broad definition

0.00

0.20

0.0

1.6

—

Pre-eclampsia

0.00

0.20

0.0

1.5

—

Other noninfective gastroenteritis and colitis

0.00

0.20

0.0

1.1

—

Diseases of oesophagus, stomach and duodenum

1.21

0.20

1.2

—

Disorders of vitreous body and globe

0.00

0.20

0.0

1.1

—

Dyspnoea

1.25

0.20

1.5

1.1

—

Diseases of veins, lymphatic vessels and lymph nodes, not elsewhere classified (FINNGEN)

1.23

0.18

1.4

1.2

—

Emergency coronary revascularization (for ACS)

1.22

0.18

1.3

1.2

—

Pain in throat and chest

1.22

0.18

1.0

1.2

—

Acute sinusitis

1.18

0.18

1.4

1.2

—

Persons encountering health services for examination and investigation

0.72

0.17

1.2

—

1.14

0.17

1.9

1.2

—

Other dorsopathies, not elsewhere classified

0.83

0.17

1.3

1.2

—

Pain (limb, back, neck, head abdominally)

1.22

0.15

1.1

1.0

—

ILD medications: prednisolone, methylprednisolone, prednisone

0.83

0.15

1.1

1.2

—

Injuries to the head

1.16

0.15

1.4

1.2

—

Exposure to other specified factors

0.80

0.14

1.0

1.2

—

Autoimmune diseases related-to ILD

0.78

0.14

1.0

1.2

—

Viral infections characterized by skin and mucous membrane lesions

0.78

0.14

1.0

1.2

—

Falls/tendency to fall

1.16

0.14

1.3

1.2

—

Type 2 diabetes, strict (exclude DM1)

0.81

0.14

1.0

1.3

—

Type 2 diabetes, definitions combined

0.81

0.14

1.0

1.3

—

Type 2 diabetes, definitions combined, including avohilmo

0.79

0.14

1.0

1.3

—

Complications of surgical and medical care, not elsewhere classified

0.83

0.14

1.3

1.2

—

Other soft tissue disorders, not elsewhere classified

0.82

0.13

1.2

—

Symptoms and signs involving cognition, perception, emotional state and behaviour

1.17

0.12

1.2

—

Caries of enamel

1.15

0.12

1.0

1.2

—

Autoimmune diseases

0.87

0.11

1.0

1.2

—

Temporomandibular joint disorders, including avohilmo

1.15

0.10

1.0

1.3

—

Suppurative and unspecified otitis media

1.11

0.10

1.6

1.3

—

Dorsopathies

0.88

0.09

1.3

1.2

—

Diabetes mellitus

0.87

0.09

1.0

1.2

—

Other diseases of intestines

1.12

0.09

1.0

1.2

—

Contraceptive management

1.03

0.09

1.0

1.2

—

Polycystic ovarian syndrome, consortium definition

1.15

0.09

1.3

1.2

—

Cholelithiasis

1.09

0.09

1.0

1.3

—

Alcohol use disorder, Swedish definition

1.10

0.09

2.0

1.2

—

Use of eye-antiallergens (taken as indicator of allergic/atopic conjunctivitis)

1.10

0.09

1.0

1.2

—

Dental caries, including avohilmo

0.82

0.08

1.2

—

External causes of morbidity and mortality

0.78

0.08

1.4

1.0

—

Allergic conjunctivitis

1.06

0.08

1.0

1.2

—

Cholelithiasis, broad definition with cholecystitis

1.04

0.08

1.0

1.3

—

Type 2 diabetes, wide definition

0.78

0.08

1.0

1.2

—

Symptoms and signs involving the urinary system

0.83

0.08

1.0

1.3

—

Major coronary heart disease event

1.11

0.08

1.3

1.2

—

Pain in joint

1.12

0.08

1.4

1.0

—

0.82

0.08

2.0

1.2

—

Dermatophytosis

0.81

0.08

1.0

1.2

—

Asthma (only as main-diagnosis)

1.07

0.08

1.0

1.2

—

Asthma (only as main-diagnosis), excluding more controls

1.05

0.08

1.0

1.2

—

Constipation

1.05

0.08

1.0

1.3

—

ILD medications: immunosuppressive drugs

1.07

0.08

1.0

1.2

—

Artificial joint operation, meniscal resection

0.79

0.07

1.0

1.2

—

Diabetes medication

0.88

0.07

1.0

1.2

—

Complications of procedures, not elsewhere classified

0.83

0.07

1.3

1.2

—

Diseases of middle ear and mastoid

1.06

0.07

1.4

1.2

—

Diseases of the musculoskeletal system and connective tissue

1.07

0.07

1.1

1.2

—

Conjunctivitis

0.85

0.07

1.0

1.2

—

Asthma, hospital admissions , main diagnosis only

0.82

0.07

1.0

1.2

—

Gastrointestinal diseases

1.02

0.07

1.6

1.2

—

Other specific joint derangements/joint disorders

1.02

0.07

1.3

1.2

—

Diseases of veins, lymphatic vessels and lymph nodes, not elsewhere classified

0.85

0.07

1.4

1.2

—

Biguanides

0.84

0.07

1.0

1.3

—

Low back pain

0.88

0.07

1.4

1.2

—

Asthma (diagnoses ohter than nonallergic)

1.02

0.07

1.0

1.2

—

Condition for Implicit Sepsis (Organ dysfunction codes)

0.85

0.07

1.4

1.2

—

Mycoses

0.86

0.06

1.0

1.2

—

Injuries to the ankle and foot

1.12

0.06

1.3

1.2

—

All kidney diseases

0.85

0.06

1.2

—

Intestinal infectious diseases

0.86

0.06

1.0

1.2

—

Parasetamol

0.90

0.05

1.8

1.1

—

Certain infectious and parasitic diseases

1.08

0.04

1.5

1.2

—

Type 2 diabetes

0.91

0.04

1.0

1.2

—

Dorsalgia

0.93

0.03

1.2

—

Asthma/COPD (KELA code 203)

1.08

0.02

1.0

1.2

—

Diseases of the eye and adnexa

0.93

0.02

1.1

1.3

—

Neoplasms

0.95

0.00

1.5

1.2

—

Benzodiazepine use

0.94

0.00

2.0

1.1

—

Endocrine, nutritional and metabolic diseases

0.96

0.00

1.0

1.3

—

Soft tissue disorders

1.00

0.00

1.2

—

Nerve, nerve root and plexus disorders

1.02

0.00

1.1

1.2

—

Hypertension

0.99

0.00

1.0

1.3

—

ILD medications

0.99

0.00

1.1

1.2

—

Lower back pain or/and sciatica

0.96

0.00

1.3

1.2

—

Cardiovascular diseases (excluding rheumatic etc)

0.96

0.00

1.4

1.2

—

Hypertension, essential

1.01

0.00

1.0

1.3

—

Cardiovascular diseases

0.99

0.00

1.4

1.2

—

Arthropathies

1.00

0.00

1.3

1.2

—

Used for control exclusion in common control thyroid runs

1.04

0.00

1.0

1.3

—

Benign neoplasms

1.02

0.00

1.5

1.1

—

First line medication for Crohn's disease

1.00

0.00

1.1

1.2

—

Inflammatory bowel disease treatment related agents

1.00

0.00

1.1

1.2

—

Hypertensive diseases

0.99

0.00

1.0

1.3

—

Oral corticosteroids

1.00

0.00

1.1

1.2

—

Other problems related to primary support group, including family circumstances

0.00

0.0

1.2

—

Other/unspecified enthesopathies of lower limb, excluding foot

0.00

0.0

1.2

—

malignant neoplasm of male genital organs

0.00

0.0

1.0

—

Cystitis

0.99

0.00

1.0

1.3

—

Disorders of optic nerve and visual pathways

0.00

0.0

1.1

—

Vulvovaginal ulceration/inflammation in other diseases

0.00

0.0

1.2

—

L04AD Calcineurin inhibitors

0.00

0.0

1.2

—

Other degenerative diseases of the nervous system

0.00

0.0

1.2

—

Brachial plexus disorders

0.00

0.0

1.1

—

Fitting and adjustment of other devices

0.00

0.0

1.2

—

Other keratitis

0.00

0.0

1.2

—

Care involving use of rehabilitation procedures

0.87

0.00

1.6

1.2

—

Schizoaffective disorder

0.00

0.0

1.2

—

Diabetic nephropathy, excluding more controls

0.00

0.0

1.0

—

Dentofacial anomalies [including malocclusion]

0.96

0.00

1.0

1.2

—

Obesity and other hyperalimentation

0.95

0.00

1.0

1.2

—

Polycystic ovarian syndrome

0.00

0.0

1.2

—

MS-disease / Multiple Sclerosis

0.00

0.0

1.1

—

Symptoms, signs and abnormal clinical and laboratory findings, not elsewhere classified

0.90

0.00

1.2

1.0

—

Excessive vomiting in pregnancy

0.00

-0.00

0.0

1.5

—

Multiple delivery

0.00

-0.00

0.0

1.0

—

Salpingitis and oophoritis

0.00

-0.00

0.0

1.3

—

Mental and behavioural disorders due to alcohol

0.98

-0.00

2.0

1.1

—

Other noninflammatory disorders of vulva and perineum

0.00

-0.00

0.0

1.7

—

Other disorders of breast

0.00

-0.00

0.0

1.3

—

Uterine polyps

0.00

-0.00

0.0

1.3

—

Ankylosing spondylitis

0.00

-0.00

0.0

1.0

—

Cervicocranial syndrome

0.00

-0.00

0.0

1.3

—

Amenorrhoea

0.00

-0.00

0.0

1.7

—

Other local infections of skin and subcutaneous tissue

0.00

-0.00

0.0

1.0

—

Other noninflammatory disorders of vagina

0.00

-0.00

0.0

1.3

—

Twin gestation

0.00

-0.00

0.0

1.1

—

Periodontitis

0.93

-0.00

1.0

1.2

—

GI-bleeding

0.00

-0.00

0.0

1.1

—

Injuries to the shoulder and upper arm

0.99

-0.00

1.3

1.2

—

Diseases of pulp and periapical tissues and dental caries

0.95

-0.00

1.2

—

Scoliosis

0.00

-0.00

0.0

1.2

—

Allergic urticaria

0.00

-0.00

0.0

1.2

—

Other noninflammatory disorders of uterus, except cervix

0.00

-0.00

0.0

1.3

—

Crossbite

0.00

-0.00

0.0

1.0

—

Female infertility, tubal origin

0.00

-0.00

0.0

1.3

—

Insulin, combination of fast acting with intermediate-acting or long-acting

1.02

-0.00

1.0

1.3

—

Unspecified lump in breast

0.00

-0.00

0.0

1.3

—

Diseases of the respiratory system

0.97

-0.00

1.2

—

Caries of dentine, including avohilmo

0.94

-0.00

1.1

—

Fibromyalgia

0.00

-0.00

0.0

1.2

—

Endometriosis of rectovaginal septum and vagina

0.00

-0.00

0.0

1.3

—

Other female pelvic inflammatory diseases

0.00

-0.00

0.0

1.5

—

Anorexia (incl.atypical)

0.00

-0.00

0.0

1.0

—

Insulin medication

0.91

-0.00

1.0

1.3

—

Psoriatic arthropathies

0.00

-0.00

0.0

1.2

—

Aortic valve malfunction, age under 60 years

0.00

-0.00

0.0

1.0

—

Mixed and other personality disorders

0.00

-0.00

0.0

1.2

—

Postprocedural endocrine and metabolic disorders, not elsewhere classified

0.00

-0.00

0.0

1.3

—

Demyelinating diseases of the central nervous system

0.00

-0.00

0.0

1.3

—

Diabetic nephropathy

0.00

-0.00

0.0

1.0

—

Diabetic maculopathy

0.00

-0.00

0.0

1.0

—

Other and unspecified disorders of vitreous body

0.00

-0.00

0.0

1.1

—

Sarcoidosis

0.00

-0.00

0.0

1.0

—

FESS (DNB20)

0.00

-0.00

0.0

1.1

—

Other ulcerative colitis

0.00

-0.00

0.0

1.2

—

Other (not insulin) diabetes medications

0.92

-0.00

1.0

1.3

—

Ethmoidectomy

0.00

-0.00

0.0

1.1

—

Asthma-related infections

0.98

-0.00

1.0

1.3

—

Noninfectious colitis NAS

0.00

-0.00

0.0

1.2

—

Other nutritional deficiencies

0.90

-0.00

1.0

1.2

—

Sequelae of infectious and parasitic diseases

0.00

-0.00

0.0

1.2

—

Chronic periodontitis, including avohilmo

0.93

-0.00

1.0

1.2

—

Hard cardiovascular diseases

0.97

-0.00

1.3

1.2

—

Fracture of femur

0.00

-0.00

0.0

1.0

—

Sequelae of other and unspecified infectious and parasitic diseases

0.00

-0.00

0.0

1.2

—

Hypertensive diseases (excluding secondary)

0.97

-0.00

1.0

1.2

—

Viral warts

0.00

-0.00

0.0

1.2

—

Other follicular disorders

0.00

-0.00

0.0

1.2

—

Atrophic disorders of skin

0.00

-0.00

0.0

1.2

—

Retention of urine

0.00

-0.00

0.0

1.2

—

Special screening examination for other diseases and disorders

0.00

-0.00

0.0

1.0

—

Persons encountering health services for specific procedures, not carried out

0.00

-0.00

0.0

1.0

—

Cardiomyopathy

0.00

-0.00

0.0

1.0

—

Other special examinations and investigations of persons without complaint or reported diagnosis

1.01

-0.00

1.1

1.2

—

Pure hypercholesterolaemia

0.91

-0.00

1.0

1.2

—

Glomerular diseases

0.00

-0.00

0.0

1.1

—

Obesity

0.95

-0.00

1.0

1.2

—

Male infertility

0.00

-0.00

0.0

1.0

—

Other behavioural and emotional disorders with onset usually occurring in childhood and adolescence

0.00

-0.00

0.0

1.2

—

Other disorders of glucose regulation and pancreatic internal secretion

0.00

-0.00

0.0

1.2

—

Coxarthrosis, primary, with hip surgery

0.00

-0.00

0.0

1.0

—

Overexertion and strenuous or repetitive movements

0.00

-0.00

0.0

1.2

—

Pedal cyclist injured in noncollision transport accidents

0.00

-0.00

0.0

1.1

—

Other external causes of accidental injury

0.93

-0.00

1.4

1.1

—

Other superficial mycoses

0.00

-0.00

0.0

1.1

—

Aneurysms, operations, SAH

0.00

-0.00

0.0

1.0

—

Foreign body entering into or through eye or natural orifice

0.00

-0.00

0.0

1.0

—

Ovarian dysfunction

0.00

-0.00

0.0

1.1

—

Nontraumatic intracranial haemmorrhage

0.00

-0.00

0.0

1.0

—

Exposure to other and unspecified inanimate mechanical forces

0.00

-0.00

0.0

1.2

—

Cirrhosis, broad definition used in the article https://doi.org/10.1101/594523

0.00

-0.00

0.0

1.0

—

Purpura and other haemorrhagic conditions

0.00

-0.00

0.0

1.2

—

Other diseases of blood and blood-forming organs, wide

0.00

-0.00

0.0

1.2

—

Fibroblastic disorders

0.00

-0.00

0.0

1.2

—

Other disorders starting during childhood or adolecense, excluding more controls

0.00

-0.00

0.0

1.2

—

Left ventricular outflow tract obstruction (LVOTO), broad definition

0.00

-0.00

0.0

1.0

—

Diseases of male genital organs

0.94

-0.00

1.4

1.1

—

Dislocation, sprain and strain of joints and ligaments of knee

0.96

-0.00

1.0

1.2

—

Other viral infections characterized by skin and mucous membrane lesions, not elsewhere classified

0.00

-0.00

0.0

1.1

—

Ulcerative proctitis

0.00

-0.00

0.0

1.2

—

Chronic kidney disease

0.00

-0.00

0.0

1.0

—

Malignant neoplasm of prostate, including Hilmo

0.00

-0.00

0.0

1.0

—

Enlarged lymph nodes

0.00

-0.00

0.0

1.1

—

Other metabolic disorders

0.00

-0.00

0.0

1.2

—

Psoriatic and enteropathic arthropathies

0.00

-0.00

0.0

1.1

—

Malignant neoplasm of digestive organs

0.00

-0.00

0.0

1.0

—

Sequelae of injuries of lower limb

0.00

-0.00

0.0

1.2

—

Polyuria

0.00

-0.00

0.0

1.2

—

L02BA Anti-estrogens

0.00

-0.00

0.0

1.4

—

Deep endometriosis

0.00

-0.00

0.0

1.6

—

Carcinoma in situ of cervix uteri

0.00

-0.00

0.0

1.9

—

Hyperfunction of pituitary gland

0.00

-0.00

0.0

1.2

—

All influenza (not pneumonia)

0.00

-0.00

0.0

1.4

—

Ulcerative rectosigmoiditis

0.00

-0.00

0.0

1.2

—

Hypertrophy of breast

0.00

-0.00

0.0

1.4

—

Certain conditions originating in the perinatal period

0.00

-0.00

0.0

1.0

—

Female infertility, associated with anovulation

0.00

-0.00

0.0

1.7

—

Asthma, hospital admission 2, infections

0.98

-0.00

1.0

1.3

—

Exclusions for E4_PCOS_CONSORTIUM

1.00

-0.00

2.1

1.1

—

Certain infectious and parasitic diseases

0.88

-0.00

1.0

1.2

—

Varicella [chickenpox]

0.00

-0.00

0.0

1.0

—

Presence of other devices

0.00

-0.00

0.0

1.2

—

Ulcerative colitis, NAS

0.00

-0.00

0.0

1.2

—

Oligomenorrhoea

0.00

-0.00

0.0

1.4

—

Diabetic neuropathy

0.00

-0.00

0.0

1.0

—

Other congenital malformations of skin

0.00

-0.00

0.0

1.2

—

Graves disease, strict definition

0.00

-0.00

0.0

1.3

—

≡ Risteys

R13

FinnGen R12 + FinRegistry

FinnGen R11 + FinRegistry

FinnGen R10 + FinRegistry

FinnGen R10

FinnGen R9

FinnGen R8

FinnGen R7

FinnGen R6

FinnGen R5

FinnGen R4

FinnGen R3

Propoxyphene + Norpropoxyphene [Presence] in Urine by Confirmatory method

Coding

Definition

OMOP mapping QC

Cohort

Year of birth distribution

Age at first measurement

Age at last measurement

Age at start of registry

Duration from first to last measurement

Statistics

Number of measurements over the years

Number of measurements per person

Distribution of lab values

Value range per person

LabWAS